Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression

More than 25% of patients diagnosed with endometrial carcinoma have invasive primary cancer accompanied by metastases. Growth hormone-releasing hormone (GHRH) plays an important role in reproduction. Here, we examined the effect of a GHRH antagonist on the motility of endometrial cancer cells and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hsien-Ming, Huang, Hong-Yuan, Schally, Andrew V, Chao, Angel, Chou, Hung-Hsueh, Leung, Peter C.K., Wang, Hsin-Shih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354842/
https://www.ncbi.nlm.nih.gov/pubmed/28032599
http://dx.doi.org/10.18632/oncotarget.13877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354842/
https://www.ncbi.nlm.nih.gov/pubmed/28032599
http://dx.doi.org/10.18632/oncotarget.13877

Ejemplares similares